Congressional Psychedelics Advancing Therapies (PATH) Caucus

The Congressional Psychedelics Advancing Therapies (PATH) Caucus is a bipartisan U.S. congressional caucus centered in federal policymaking and legislative advocacy. It operates nationally in Congress and is co-chaired by Representatives Lou Correa and Jack Bergman, with a stated focus on evidence-based psychedelic science, clinical research, and federal pathways for lawful therapeutic use. Its public-facing work is especially tied to veterans and the Department of Veterans Affairs.

In psychedelic medicine, the caucus frames its role as promoting rigorous clinical research and increasing awareness among lawmakers and the media about FDA-approved psychedelic trials, rather than legalization or recreational use. Documented current efforts include meetings with VA leadership, support for VA research and access planning, a 2025 bill to create Veterans-focused centers of excellence, and earlier amendments and requests aimed at expanding federal study of psychedelic-assisted therapies for PTSD, depression, and substance use disorder. Practical collaboration opportunities are strongest for researchers, clinicians, funders, policy groups, and veteran-serving communities working on study design, implementation, access planning, and evidence translation.